OXEIA Trademark

Trademark Overview


On Thursday, October 28, 2021, a trademark application was filed for OXEIA with the United States Patent and Trademark Office. The USPTO has given the OXEIA trademark a serial number of 97097829. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Friday, February 9, 2024. This trademark is owned by Oxeia Biopharmaceuticals, Inc.. The OXEIA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for use in neurotrauma and neurology; pharmaceutical preparations for treating concussions, brain injuries and dysfunctions, neurodegeneration, and neurologic diseases, conditions, and disorders; therapeutic preparations for use in neurotrauma and neurology for stabilizing brain metabolism and energy

Pharmaceutical research and development; providing medical and scientific research information in the fields of concussions, brain injury, neurodegeneration, and neurology
oxeia

General Information


Serial Number97097829
Word MarkOXEIA
Filing DateThursday, October 28, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateFriday, February 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of a silhouette of a person's head with the top half consisting of non-connecting triangles.
Goods and ServicesPharmaceutical preparations for use in neurotrauma and neurology; pharmaceutical preparations for treating concussions, brain injuries and dysfunctions, neurodegeneration, and neurologic diseases, conditions, and disorders; therapeutic preparations for use in neurotrauma and neurology for stabilizing brain metabolism and energy
Goods and ServicesPharmaceutical research and development; providing medical and scientific research information in the fields of concussions, brain injury, neurodegeneration, and neurology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 10, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxeia Biopharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02115

Trademark Events


Event DateEvent Description
Friday, February 9, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, February 9, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, August 12, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, February 12, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, February 12, 2023LETTER OF SUSPENSION E-MAILED
Sunday, February 12, 2023SUSPENSION LETTER WRITTEN
Thursday, February 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 9, 2022NON-FINAL ACTION E-MAILED
Tuesday, August 9, 2022NON-FINAL ACTION WRITTEN
Saturday, August 6, 2022ASSIGNED TO EXAMINER
Thursday, November 11, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, November 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 1, 2021NEW APPLICATION ENTERED